Lyka Labs Secures Indian Patent for Pregabalin Gel for Neuropathic Pain

Lyka Labs Limited has revealed that it has received an Indian Patent for its unique product, Pregabalin Gel 8 percent, with patent protection lasting until 2043.

Apollo Report Reveals Undiagnosed Chronic Illness Crisis in India

New research from Apollo Hospitals shows the lurking crisis of undiagnosed chronic diseases for millions in India's healthcare scenario. On screenings conducted of 2.5 million across the national hospital network, the...

Experts Urge Review of Pharma Imports as US Tariff Barriers Rise

Industry leaders want the Indian government to undertake an entire impact and vulnerability study to identify the risk associated with importing...

AstraZeneca India gets CDSCO nod to import, distribute Osimertinib drug

AstraZeneca Pharma India Limited has received the authorization from the Central Drugs Standard Control Organization (CDSCO), Directorate General of Health Services, Government of India, to import and market Osimertinib Tablets 40 mg & 80 mg....

Govt & Medtech Firms to Boost Indigenous Development of Advanced Equipment

In terms of using these medical devices, India imports almost 80 to 85 percent of them; hence, the government and the private sector are prompted towards the idea...

Novo Nordisk Eyes Indian Market for Weight-Loss Drug Wegovy Launch

In a rapidly evolving Indian Pharmaceutical market, the growing demand for Obesity and diabetes drugs market is witnessing a huge heap through the continuous innovations by the leading companies. Notably, Danish pharm firm Novo Nordisk has announced

Sun Pharmaceutical has launched a medication to treat Erosive Esophagitis

Sun Pharmaceutical Industries has introduced Fexuclue in India, which comprises Fexuprazan tablets (40mg) to treat...

Rajnath Singh Urges AMC to Embrace Tech for Better Healthcare Services

While the Raksha Mantri acknowledged AMC's initiatives of adopting Artificial Intelligence (AI) and carrying out research into advanced technologies, he focused on the requirement of keeping up with evolving practices to bring about a new wave of

Abbott unveils new delivery system for electrode implantation procedure

A “next-generation” delivery system has been launched by Abbott to streamline the electrode implantation process for its Proclaim DRG neurostimulation system.

Trump Tariffs likely to Hamper Growth of Indian Medical Device Exports

The Indian medical devices industry is facing a major challenge as the US imposes a 26% tariff on exports, impacting a sector striving to replicate the success of India’s pharmaceutical industry. With India’s medical device exports to the US valued a

© 2025 India Pharma Outlook. All Rights Reserved.